Suppression of β-catenin signaling by liver X receptor ligands

Shigeyuki Uno, Kaori Endo, Yangsik Jeong, Katsuyoshi Kawana, Hiroyuki Miyachi, Yuichi Hashimoto, Makoto Makishima

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The nuclear receptors liver X receptor (LXR) α and LXRβ serve as oxysterol receptors and play an important role in the regulation of lipid metabolism. We investigated the potential effects of LXRs on pathways of colon carcinogenesis and found that LXR activation suppresses the transactivation activity of β-catenin, a key molecule in Wnt signaling. LXRα and LXRβ inhibited β-catenin transactivation of T cell factor-mediated transcription in a ligand-dependent manner. LXR activation suppressed an oncogenic β-catenin, which has phosphorylation site mutations, and did not change β-catenin protein expression in cells. In contrast, β-catenin enhanced LXR transactivation activity. Nuclear LXRs and β-catenin were coimmunoprecipitated in colon cancer HCT116 cells, and in vitro experiments showed that LXRs bind directly to the Armadillo repeat region of β-catenin in a ligand-independent manner. LXR ligand decreased mRNA expression of β-catenin targets, MYC, MMP7 and BMP4, and recruited LXRs to MYC and MMP7 promoters. Transfection of a dominant negative LXR to HCT116 cells and experiments using LXR-null cells showed the involvement of cellular LXRs in β-catenin suppression and proliferation inhibition. The results show lipid-sensing receptor LXRs regulate the β-catenin activity and cellular proliferation.

Original languageEnglish
Pages (from-to)186-195
Number of pages10
JournalBiochemical Pharmacology
Volume77
Issue number2
DOIs
Publication statusPublished - Jan 15 2009

Keywords

  • Colon cancer
  • Liver X receptor
  • Nuclear receptor
  • Proliferation
  • Transcription
  • β-Catenin

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Fingerprint Dive into the research topics of 'Suppression of β-catenin signaling by liver X receptor ligands'. Together they form a unique fingerprint.

  • Cite this

    Uno, S., Endo, K., Jeong, Y., Kawana, K., Miyachi, H., Hashimoto, Y., & Makishima, M. (2009). Suppression of β-catenin signaling by liver X receptor ligands. Biochemical Pharmacology, 77(2), 186-195. https://doi.org/10.1016/j.bcp.2008.10.007